CANF
Can-fite Biopharma·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CANF fundamentals
Can-fite Biopharma (CANF) expects to report earnings on Mar 28, 2024, with estimated revenue of -- (YoY 0.00%), and EPS at -0.26 (YoY +76.58%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-0.26
+76.58%
Report date
Mar 28, 2024
EPS
Revenue
Revenue & Expenses
CANF has released its 2023 Q4 earnings report, with revenue of 155.00K, reflecting a YoY change of -21.32%, and net profit of -1.65M, showing a YoY change of 45.28%. The Sankey diagram below clearly presents CANF's revenue sources and cost distribution.
Key Indicators
Can-fite Biopharma (CANF) key financial stats and ratios, covering profitability, financial health, and leverage.
Can-fite Biopharma (CANF)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Can-fite Biopharma (CANF)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Can-fite Biopharma (CANF)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Can-fite Biopharma (CANF) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Can-fite Biopharma (CANF) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Can-fite Biopharma's latest dividend and current dividend yield?What is the market's earnings forecast for Can-fite Biopharma next quarter?Did Can-fite Biopharma beat or miss consensus estimates last quarter?What guidance did Can-fite Biopharma's management provide for the next earnings period?What does Can-fite Biopharma do and what are its main business segments?What were the key takeaways from Can-fite Biopharma's earnings call?What were the key takeaways from Can-fite Biopharma’s earnings call?What is Can-fite Biopharma's gross profit margin?
